Save time and get answers to complex questions with AI chat
Excipients list used in dexamethasone creams?Norcuron generic name?Defense strategy against generic in niche market?Dabrafenib and trametinib price?When will there be a generic loreev available?
See the DrugPatentWatch profile for dayvigo
No, you should not take Dayvigo (lemborexant) if you have sleep apnea. The prescribing information explicitly contraindicates it in patients with moderate or severe obstructive sleep apnea (OSA) due to risks of respiratory depression and further airway obstruction during sleep.[1] Lemborexant, an orexin receptor antagonist, can suppress arousal mechanisms that help maintain breathing in sleep apnea patients.
Dayvigo reduces wakefulness by blocking orexin, which may worsen apnea events by impairing the brain's ability to respond to low oxygen or high CO2 levels. Clinical trials excluded patients with moderate/severe OSA, but data in mild OSA showed no major issues at approved doses (5 mg or 10 mg). Still, the FDA label bans it for moderate/severe cases to avoid exacerbating central or obstructive apnea.[1][2]
Limited data suggest Dayvigo may be tolerable in mild OSA, but only under close medical supervision with monitoring like pulse oximetry. Consult your doctor for a sleep study review; they might adjust CPAP settings or opt for alternatives.[1]
See a sleep specialist before starting any sleep aid. Untreated apnea plus Dayvigo raises risks of hypoxia, heart strain, or sudden worsening. Share your apnea severity (AHI score) and current treatments. Sources: [1]: Dayvigo Prescribing Information (FDA) [2]: Eisai Dayvigo Safety Profile [3]: American Academy of Sleep Medicine Guidelines
Other Questions About Dayvigo :